INTELLIA THERAPEUTICS INC
NTLA·45826J105·US·Common Stock·Healthcare - Biotechnology-13D/G
NTLA (INTELLIA THERAPEUTICS INC) is held by 155 institutional investors as of Q1 2026. Largest holders: ARK Investment Management LLC ($186M), BlackRock, Inc. ($155.8M), STATE STREET CORP ($88.7M). Net institutional sentiment: Mixed.
155
Holders
Avg rating(34 Elite)
$1.3B
Total Value
65% (171)
Fund Consensus
104 buying - 56 selling
Who's Trading
InsiderDPDube Michael PSell $44KJul 1, 2026
InsiderBJBASTA JAMESSell $17KMar 2, 2026
InsiderCEClark ElianaSell $8KMar 2, 2026
ActivistCIContrarius Investment Management Ltd0.6%Feb 11, 2026
InsiderLMLEONARD JOHN MSell $314KJan 5, 2026
13F: Insider & Congress:
Showing 1-20 of 171
1 / 9
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer